BioHealth News Archive
Synthetic cells could be the future of drug delivery – FierceDrugDelivery
In the world of drug development, honing an effective molecule is just the first step. As everyone in the drug delivery business knows, issues…
Read More
Hamner: Biotech growth to last until 2035 – Triangle Business Journal
Dr. Charles Hamner has been researching the nanotechnology industry since, as he puts it, “before they called it nanotechnology.” But he says it’s not…
Read More
Cerecor, biotech startup headed by Blake Paterson, raises $22M – Baltimore Business Journal
Cerecor Inc., a Baltimore biotech startup headed by former Alba Therapeutics CEO Dr. Blake Paterson, has raised $22 million in a Series A financing…
Read More
InvestMaryland VC firms to be recommended by London’s Altius Associates – Baltimore Business Journal
Maryland has chosen a London firm to oversee the selection of venture capital firms interested in making investments in young state companies through the…
Read More
NIH and Lilly Collaborate, Aim to Make Drug Development Pipelines More Productive | Highlight HEALTH
Over the past decade, collaborative research efforts to support the discovery and development of medicines has increased dramatically. Last month, the National Institutes of…
Read MoreMedImmune central to AstraZeneca-Amgen antibody deal – Washington Business Journal
Pharmaceutical giants AstraZeneca PLC and Amgen Inc. just announced a deal to co-develop and co-commercialize five product candidates, all monoclonal antibodies. No surprise here: LLC …
Read More
Biotech Can’t Sidestep Cost-Effectiveness Anymore | Xconomy
Back in the old days of biotech, the business was pretty straightforward. You’d craft your scientific idea, aim a new drug at patients in need,…
Read More
What venture capitalists look for in personalized medicine investments
Companies like Starbucks (NASDAQ:SBUX), Amazon.com (NASDAQ:AMZN) and Apple (NASDAQ:AAPL) aren’t healthcare companies, but one venture capitalist believes their example can guide personalized medicine. Bob…
Read More
Gene mapping isn’t a crystal ball for future health… yet – NY Daily News
Gene scans for everyone? Not so fast. New research suggests that for the average person, decoding your own DNA may not turn out to…
Read More
Emergent’s Fuad El-Hibri, an entrepreneur at heart
Fuad El-Hibri has started a financial consulting business. He’s started telecommunications businesses. But his most challenging venture has been the Rockville biotech he helped…
Read More
UNH Center for Venture Research: U.S. Angel Investor Market on Solid Path of Recovery in 2011
Following a considerable contraction in investment dollars in 2008 and 2009, the U.S. angel investor market continued to recover in 2011, a trend that…
Read More
AstraZeneca links up with Amgen for treatments development
Shares in AstraZeneca ticked up after the Anglo-Swedish drugs giant announced a tie-up with biotechnology giant Amgen to develop and commercialise five treatments. Under…
Read More
Big Pharma Cozies Up to Biotech – DailyFinance
Pharmaceuticals have figured that out that if they can't be as innovative or nimble as biotechs, the next best option is to pay for…
Read More
Johns Hopkins top R&D spender for 32nd straight year in 2010 – Baltimore Business Journal
Surprise, surprise — Johns Hopkins University spent more money on medical, science and engineering research than any other university in fiscal 2010. Hopkins…
Read More
Video Interview: America’s CTO Catalyzes Health Entrepreneurship through Open Data
No matter how privatized healthcare is in America, at the end of the day it remains a social sustainability issue and a government concern.…
Read More